The Hemodialysis Pain Reduction Effort (HOPE) is a research study specifically for people being treated with hemodialysis. The main goal of the study is to test interventions designed to reduce the impact that chronic pain has on how people feel and function. The HOPE Trial is part of the National Institutes of Health HEAL Initiative to find scientific solutions to stem the national opioid health crisis.
The study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, also known as NIDDK.
Haga clic en el botón de inicio para obtener más información sobre HOPE de nuestros consejeros de pacientes.
The HEAL (Helping to End Addiction Long-termTM) Initiative is a National Institutes of Health (NIH) funded, trans-agency effort to find scientific solutions to stem the national opioid public health crisis. The initiative is funding hundreds of projects like HOPE nationwide to address the opioid epidemic through one of two mechanisms; trying to understand, manage, and treat pain; or improving treatment for opioid misuse and addiction.
Link to HEAL website https://heal.nih.gov/
How can I participate?
HOPE is a research study about pain experienced by people who receive treatment with hemodialysis. The goal of HOPE is to improve pain and reduce the negative impact it has on people’s lives.
If you regularly experience pain and would like to see if HOPE might be a good fit for you, please click the button below to complete a short survey.
Research is important because it allows us to learn new information that can help to improve the lives of others. If you are interested in learning more about the importance of research, especially in the area of hemodialysis, watch this video for more information.
Why is research important?
“Dialysis Research” Copyright © 2018 The University of North Carolina at Chapel Hill